Compare iShares MSCI ACWI ETF (ACWI) vs Amylx Pharmaceuticals Inc (AMLX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares MSCI ACWI ETF vs Amylx Pharmaceuticals Inc — how do they compare? iShares MSCI ACWI ETF trades at $161.9, while Amylx Pharmaceuticals Inc trades at $23.65 (market cap $2.64B). Which is the better fit depends on your goals.
| ACWI | AMLX | |
|---|---|---|
52-Week High | $161.44 | $24.19 |
52-Week Low | $132.04 | $7.82 |
Market Cap | — | $2.64B |
Sector | — | Health |
Enterprise Value | — | $2.39B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About iShares MSCI ACWI ETF
The fund generally will invest at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index. The index is a free float-adjusted market capitalization index designed to measure the combined equity market performance of developed and emerging markets countries.
Read more on ACWI →About Amylx Pharmaceuticals Inc
Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.
Read more on AMLX →
